LJPC-501
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for LJPC-501, covering 2016-03-03 to 2018-08-09. Get the full timeline:
Most recent: Clinical Trial Update: A Study of LJPC-501 in Paediatric Patients With Hypotension Associated With Distributive or Vasodilatory Shock [Phase 2]